• Portfolio
    • Next Investors
    • Catalyst Hunter
    • Wise-Owl
    • Next Biotech
    • Emerge
  • Latest Articles
  • Weekenders
  • Quick Takes
  • Education
  • Trust

  • Portfolio
    • Next Investors
    • Catalyst Hunter
    • Wise-Owl
    • Next Biotech
    • Emerge
  • Latest Articles
  • Weekenders
  • Quick Takes
  • Education
  • Trust
  1. Home
  2. Ritual Green

Ritual Green

Creso Pharma

Creso Pharma's Mernova enters Canada’s largest recreational cannabis market

Finfeed Archived Feb 17, 2021

Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced that its wholly-owned Canadian subsidiary Mernova Medicinal Inc. has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$502,199).

Creso Pharma

Creso Pharma bags four new orders and launches Black Mamba

Finfeed Archived Feb 03, 2021

Investors who took a stake in Creso Pharma (ASX:CPH) three months ago are now looking at a near ten-bagger, with more upside to come.

Creso Pharma

Creso Pharma delivers third order of Ritual Green brand

Finfeed Archived Oct 27, 2020

Through its Mernova subsidiary, Creso Pharma (ASX: CPH) has delivered its third purchase order (PO) from the Nova Scotia Liquor Corp

Creso Pharma

Creso Pharma’s Mernova receives initial purchase order

Finfeed Archived Sep 21, 2020

Creso Pharma’s (ASX:CPH) Mernova Medicinal Inc based in Nova Scotia has received an initial purchase order for its cannabis products

Get expert stock analysis direct in your inbox

Join Our
Mailing List

Footer

Portfolio

  • Next Investors
  • Wise Owl
  • Catalyst Hunter
  • Next Biotech
  • Emerge

Support

  • Contact Us
  • Trust Centre
  • How it Works
  • History
  • FAQ
  • Definitions
  • Archived Articles
  • Bottom Drawer Portfolio

Policies

  • Customer Notice
  • Disclosure Policy
  • Financial Services Guide
  • ESG Policy
  • Privacy Policy

Subscribe Next Investors

Daily write ups on small cap stocks we are invested in:


Next Investors

This material has been prepared by S3 Consortium Pty Ltd (trading as StocksDigital). S3 Consortium Pty Ltd is a Corporate Authorised Representative (CAR 000433913) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573) (62C).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Price, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, Price, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.


© 2026 nextinvestors.com | All rights reserved

Follow Us